RJMG vs. ARKG ETF Comparison
Comparison of FT Raymond James Multicap Growth Equity ETF (RJMG) to ARK Genomic Revolution Multi-Sector ETF (ARKG)
RJMG
FT Raymond James Multicap Growth Equity ETF
RJMG Description
Under normal market conditions, the fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in a portfolio of equity securities. The fund seeks to achieve its objective by investing in a portfolio of U.S.-listed equity securities, including common stocks and real estate investment trusts ("REITs") that exhibit growth characteristics and are rated "Strong Buy" or "Outperform" by a model developed and overseen by the fund"s non-discretionary investment sub-advisor, Raymond James & Associates, Inc. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$24.53
Average Daily Volume
587
40
ARKG
ARK Genomic Revolution Multi-Sector ETF
ARKG Description
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.Grade (RS Rating)
Last Trade
$23.22
Average Daily Volume
2,215,896
34
Performance
Period | RJMG | ARKG |
---|---|---|
30 Days | 4.71% | -3.53% |
60 Days | 5.79% | -11.54% |
90 Days | 8.07% | -13.90% |
12 Months | -15.87% |
1 Overlapping Holdings
Symbol | Grade | Weight in RJMG | Weight in ARKG | Overlap | |
---|---|---|---|---|---|
NTRA | A | 3.08% | 3.82% | 3.08% |
RJMG Overweight 39 Positions Relative to ARKG
Symbol | Grade | Weight | |
---|---|---|---|
SPOT | B | 2.99% | |
HUBS | A | 2.98% | |
RDNT | B | 2.91% | |
FTNT | C | 2.81% | |
THC | D | 2.81% | |
GDDY | A | 2.79% | |
QTWO | A | 2.78% | |
CRWD | B | 2.77% | |
CRM | B | 2.73% | |
AMZN | C | 2.7% | |
WIX | A | 2.68% | |
SHAK | C | 2.62% | |
MSI | B | 2.62% | |
HPE | B | 2.6% | |
PLXS | B | 2.59% | |
GOOGL | C | 2.55% | |
DECK | A | 2.52% | |
GWRE | A | 2.51% | |
NVDA | B | 2.51% | |
BSX | A | 2.5% | |
COST | A | 2.5% | |
ALL | A | 2.5% | |
WELL | A | 2.49% | |
WMT | A | 2.46% | |
META | D | 2.41% | |
MSFT | D | 2.4% | |
PG | C | 2.39% | |
OSCR | D | 2.37% | |
AAPL | C | 2.35% | |
PSN | D | 2.32% | |
KLAC | F | 2.32% | |
CL | D | 2.3% | |
MU | D | 2.23% | |
UBER | F | 2.22% | |
WING | D | 2.18% | |
AMT | C | 2.12% | |
NEM | D | 2.03% | |
MYGN | F | 1.74% | |
MPWR | F | 1.56% |
RJMG Underweight 33 Positions Relative to ARKG
Symbol | Grade | Weight | |
---|---|---|---|
TWST | F | -8.37% | |
RXRX | F | -7.42% | |
CRSP | D | -7.34% | |
ADPT | C | -5.03% | |
CDNA | D | -4.77% | |
VCYT | B | -4.51% | |
SDGR | C | -4.14% | |
BEAM | D | -4.01% | |
NTLA | F | -3.89% | |
IONS | F | -3.85% | |
NRIX | C | -3.78% | |
TXG | F | -3.56% | |
GH | B | -3.49% | |
ARCT | F | -3.19% | |
PSNL | D | -2.7% | |
ABSI | F | -2.19% | |
PACB | F | -2.16% | |
BFLY | B | -1.71% | |
VEEV | C | -1.7% | |
AMGN | F | -1.68% | |
ACCD | D | -1.47% | |
VRTX | D | -1.29% | |
ILMN | C | -1.25% | |
CERS | D | -1.18% | |
INCY | C | -1.11% | |
REGN | F | -0.92% | |
PRME | F | -0.9% | |
CMPS | F | -0.75% | |
MASS | F | -0.69% | |
QSI | C | -0.68% | |
EXAS | D | -0.65% | |
RPTX | F | -0.64% | |
MRNA | F | -0.01% |
RJMG: Top Represented Industries & Keywords
ARKG: Top Represented Industries & Keywords